UCB SA

UCB.BR · Moat type: REGULIERUNG

MoatScore

9/10

Fair Value

219 EUR (≈ 250.21 USD)

Margin of Safety

-6.0 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL UCB SA is a biopharmaceutical company specializing in the development, manufacturing, and marketing of medications in the fields of neurology and immunology, generating its revenue primarily through patent-protected specialty pharmaceuticals.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.